Related Experiment Video
Updated: Jun 8, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cyclin D1 regulates p27(Kip1) stability in B cells
Sophie Bustany1, Guergana Tchakarska, Brigitte Sola
1Biologie Moléculaire et Cellulaire de la Signalisation, EA 3919, IFR ICORE, Université de Caen Basse-Normandie, Caen Cedex, France. sophie.bustany@aliceadsl.fr
Aberrant cyclin D1 expression traps p27(Kip1) in B lymphocytes without altering cell cycle progression. This finding offers new insights into aggressive lymphoma physiopathology.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- p27(Kip1) is a key cyclin-dependent kinase inhibitor regulating the G(1)/S cell cycle transition.
- Its activity is modulated by interactions with D-type cyclins.
- Understanding these interactions is crucial for comprehending cell cycle control and diseases like lymphoma.
Purpose of the Study:
- To investigate the impact of induced cyclin D1 expression on p27(Kip1) behavior in B lymphocytes.
- To determine if cyclin D1 overexpression affects p27(Kip1) degradation, localization, and G(1)/S transition.
- To explore the relevance of these mechanisms in the context of aggressive lymphomas.
Main Methods:
- Generation of the BD1-9 cell line (BaF3 pro-B cells) for inducible cyclin D1 expression.
- Analysis of p27(Kip1) accumulation, phosphorylation (pSer10-p27(Kip1)), and degradation pathways.
- Utilizing siRNA to assess the role of p27(Kip1) in cell cycle distribution.
- Investigating CDK2 activity and protein interactions.
Main Results:
- Induced cyclin D1 expression led to p27(Kip1) accumulation, specifically the pSer10-p27(Kip1) form.
- Cyclin D1 binding inhibited p27(Kip1) degradation via the KPC proteasome pathway.
- Nuclear CDK2 activity and G(1)/S transition remained unaffected despite increased p27(Kip1).
- p27(Kip1) inhibition did not alter cell cycle phase distribution.
Conclusions:
- Aberrant cyclin D1 expression acts as a p27(Kip1) trap in B lymphocytes.
- This trapping does not cause p27(Kip1) relocation from the nucleus or modulate G(1)/S transition.
- The findings provide insights into the physiopathology of aggressive lymphomas characterized by aberrant cyclin D1.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
DNA Damage Can Stall the Cell Cycle

